HDS
Brest, France
HDS
Brest, France

Time filter

Source Type

SAN JOSE, Calif., March 2, 2017 /PRNewswire/ -- Cadence Design Systems, Inc. (NASDAQ: CDNS) today announced that Digital Media Professionals is using the Cadence® Palladium® XP Verification Computing Platform along with the company's Hosted Design Solutions (HDS) to expand its emulation...


News Article | February 28, 2017
Site: www.greencarcongress.com

« Volkswagen Group has 37 competence centers and IT labs working on future mobility solutions | Main | POET-DSM plans on-site enzyme manufacturing facility at Project Liberty cellulosic ethanol plant » Scientists led by a team at Caltech and BP, and in collaboration with researchers at UCLA, ETH Zürich, and China’s Nanjing University, have developed a new method for potentially removing nearly all sulfur compounds (down to ~2 ppm) from gas and diesel fuel. The method uses Earth-abundant materials (potassium (K), oxygen (O), and silicon (Si)—hence its name, “KOSi”) and operates under mild conditions. Sulfur compounds in fuels such as gasoline and diesel create air pollution when the fuel is burned. To address that challenge, large-scale hydrodesulfurization (HDS) at refineries remove the majority of sulfur from fuel down to a government-mandated level. The new technique, however, has the potential to reduce sulfur down to a fraction of that amount, which would further reduce air pollution and extend the lifetime of vehicles’ catalytic converters, which control tailpipe emissions. A paper on their work is published in the journal Nature Energy. Currently, HDS is performed by treating petroleum with H at high pressures and temperatures (that is, 150–2,250 psi and 400 ˚C) over heterogeneous catalysts such as cobalt-doped molybdenum sulfide supported on alumina … However, certain organosulfur species…are not efficiently removed. Homogeneous strategies employing sophisticated, well-defined transition metal complexes—including those based on platinum, nickel, tungsten, molybdenum, palladium, ruthenium, rhodium, iron, cobalt, and others—have been extensively investigated. While these studies have provided valuable mechanistic insights, several fundamental issues … generally restrict industrial implementation of such methods. … These issues pose a formidable challenge for the development of new HDS methods. Moreover, increasingly strict governmental regulations require limiting the sulfur content in diesel fuel and gasoline (in the US: typically The new method uses a potassium salt to induce the chemical reactions required to remove sulfur from fuel. Potassium is an abundant element on Earth and cheaper and more environmentally friendly to use than rare metal catalysts that are used for similar reactions. The discovery that potassium salts can be used to promote key chemical reactions came unexpectedly a couple of years ago. Researchers in the Grubbs laboratory had been testing ways to break carbon-oxygen bonds, which is most efficient when done with a precious metal catalyst such as platinum. Alexey Fedorov of ETH Zürich, who was a postdoctoral fellow in the Grubbs laboratory at the time, ran a control experiment without the metal catalyst and found that the reaction still worked. After several tests, the researchers confirmed that a potassium salt, called potassium tert-butoxide, was, in fact, driving the reaction. Next, Anton Toutov, a graduate student in the lab of Robert Grubbs, the Victor and Elizabeth Atkins Professor of Chemistry at Caltech, optimized the process and further showed that the reaction produced compounds with carbon-silicon bonds, which normally require metal catalysts to form. Carbon-silicon bonds are found in many products, such as polymers, agricultural chemicals, and semiconductors. As described in the Nature Energy paper, Toutov and his colleagues in the Grubbs lab have used the potassium salt method to remove sulfur from carbon compounds found in diesel fuel. They partnered with BP to test their method on the company’s refined diesel samples, reducing the sulfur levels down from 8 parts per million (comparable to the highest quality of diesel you can get from a typical gas pump today) to an extremely low 2 parts per million. They also repeated the experiment with diesel spiked with high levels of sulfur and achieved similar results. The new method could be used as an additional step in the oil refining process to get rid of the last traces of sulfur in fuels. Toutov is co-founding a new company, Fuzionaire, to commercialize this technology. The research was funded by BP. Support for Toutov was also provided by the Resnick Sustainability Institute at Caltech, Dow Chemical Company, Bristol-Myers Squibb, and the Natural Sciences and Engineering Research Council of Canada.


News Article | February 15, 2017
Site: www.marketwired.com

C-CORE results prove precision performance of Hifi's HDS™ technology with no false positives in real time CALGARY, AB--(Marketwired - February 15, 2017) - Hifi Engineering Inc. ("Hifi"), a developer and supplier of leading edge fiber optic sensing technologies used to monitor gas and fluid flow in pipelines and oil and gas wells, today announced results of its High-fidelity dynamic (acoustics, temperature, strain) sensing HDS™ technology as part of their testing with C-CORE, a Canadian research and development (R&D) corporation. The program was funded by LOOKNorth, a national Centre of Excellence for Commercialization and Research hosted by C-CORE. The C-CORE results proved the Hifi HDS system successfully detected all leaks generated during this testing program, with no false positives in real time. Operating pressures ranged from 195psi down to 3psi, for both liquids and gas, in both offshore and land applications. "We are very pleased with the performance of our HDS technology", said John Hull, Hifi's Founder and Chief Technology Officer. "To achieve 100% performance with no false positives proves our technology is world class, and ready to assist the industry in achieving 100% pipeline safety. These results reaffirm the performance also demonstrated through Hifi's many field pilots and commercial installations." Hifi's HDS high definition technology monitors every centimeter of a pipeline, 24 hours per day, and can detect flows less than a liter within seconds. It includes proprietary, fiber optic cables optimized for sensing, as well as optical hardware and software for permanent deployment and continuous monitoring. The patented software algorithms are designed to correlate acoustic, temperature and vibration / strain data in real-time to discern operating conditions such as excessive strain, thermal events, and security intrusions, which if left unaddressed, could evolve into a leak in the pipeline. The HDS system can also detect extremely low flow and pinhole sized leaks, with the ability to alarm and notify the pipeline operator in seconds, through a control room software powered by GE Predix™. As previously announced, Hifi has been working with Enbridge's Pipeline Control Systems and Leak Detection team to evaluate Hifi's HDS technology, along with other joint industry partners Kinder Morgan Canada and TransCanada Pipelines, through C-FER Technologies' External Leak Detection System Evaluation Program in Edmonton. The positive performance of Hifi's HDS system comes on the successful completion of the previously announced project investment between Hifi and Sustainable Development Technology Canada (SDTC), on behalf of the Government of Canada. The project from SDTC's SD Tech Fund, was $2.0M as part of a $6.0M development initiative of Hifi's next generation HDS technology for preventative pipeline leak detection. "SDTC is proud to see the investment into this innovative pipeline leak detection technology result in this successful demonstration. The HDS technology has the potential to reduce the incidence of leaks, and increase the confidence of the public in our pipeline system in Canada. We are encouraged by this, and remain optimistic in the success of this project with Hifi Technologies", said Leah Lawrence, president and CEO, Sustainable Development Technology Canada. "HiFi Engineering's technology is proof of the importance of investing in energy innovation", said Navdeep Bains, Minister of Innovation, Science and Economic Development. "Our Government is proud to support Canadian companies that are focused on developing clean technologies. These companies will create new products and services that are more energy efficient, emit lower carbon emissions and promote healthier communities. Clean technology producers will also create entirely new jobs and business opportunities for Canadians. That's how innovation makes a better Canada." About Hifi Hifi is a privately held Canadian company, with minority ownership from Enbridge and Cenovus, specializing in the research, development, supply and commercial operation of next generation fiber optic sensing technologies primarily used to monitor gas and fluid flow in oil and gas wells, and preventative leak detection for pipelines. Headquartered in Calgary, Alberta, Hifi currently has a number of commercialized products, including its HDS™ MiCro tool offering for downhole flow applications, and HDS™ MaCro system for permanent monitoring of pipelines and reservoirs. For more information, visit www.hifieng.com. About C-CORE C-CORE is an ISO 9001-registered R&D organization established in 1975 and headquartered in St. John's, Newfoundland and Labrador (NL). With unparalleled harsh-environment expertise and world-leading technical capability in Remote Sensing, Ice Engineering and Geotechnical Engineering, C-CORE provides research-based advisory services and technology solutions to help clients mitigate operational risk in harsh environments and to address security, sustainability and safety issues related to their regulatory and operating needs worldwide. About LOOKNorth LOOKNorth is a Canadian national Centre of Excellence for Commercialization and Research hosted by C-CORE. LOOKNorth fosters remote sensing innovation and promotes the use of remote sensing technologies in environmental monitoring as a way to assist decision-making and reduce uncertainties, risk and cost in challenging environments. LOOKNorth helps connect remote sensing innovators with end users facing a monitoring challenge. About SDTC Sustainable Development Technology Canada is an arm's-length foundation created by the Government of Canada to promote sustainable development and support projects that develop and demonstrate new technologies to address issues related to climate change, air quality, and clean water and soil. Sustainable Development Technology Canada invests in Canadian companies that, through their innovative technologies, contribute positively to Canada by creating quality jobs, driving economic growth and protecting the environment. For more information, visit www.sdtc.ca.


NEW YORK, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that a retrospective, multicenter study demonstrated that 45.7 percent of patients with ocular melanoma that metastasized to the liver who underwent percutaneous hepatic perfusion (PHP) using investigational Melphalan/HDS experienced a complete or partial response. The study further showed that among those who responded to treatment, overall survival was projected to be more than three years. The findings were reported at the Regional Cancer Therapies 12th International Symposium in an oral presentation titled, "Percutaneous Hepatic Perfusion for Unresectable Metastatic Ocular Melanoma to the Liver: A Multi-Institutional Report of Outcomes." The analysis was conducted by teams from Moffitt Cancer Center in Tampa, Fla., and the University Hospital Southampton in the United Kingdom. The presentation was led by Dr. Alexandra Gangi of the Moffitt Cancer Center. The analysis reviewed outcomes of 49 patients treated between 2008 and 2016 with Melphalan/HDS at either the Moffitt Cancer Center or the University Hospital Southampton. Patients underwent a total of 115 PHP treatments. The median number of treatments per patient was two, with patients receiving one-to-six treatments. PHP is a minimally invasive procedure that isolates the liver from the body’s circulatory system, so that a high dose of chemotherapy (melphalan hydrochloride) may be infused directly into the liver. Blood from the liver is then filtered to remove the chemotherapeutic agent thereby minimizing systemic exposure. Hepatic response to PHP was evaluable in 46 patients, among whom 45.7 percent showed complete or partial response, and 37.0 percent had stable disease. Median overall survival was not reached, but was projected to be 657 days (1.8 years). Among patients with a complete or partial response, overall survival was projected to be 1,207 days (3.4 years). Most common side effects following treatment were anemia, thrombocytopenia and neutropenia. “Patients diagnosed with metastatic ocular melanoma to the liver have an average of 6-8 months of survival.  This retrospective analysis reported a much longer survival after Melphalan/HDS , and provided an interesting long-term look at patient outcomes after treatment with Delcath Melphalan/HDS,” said Dr. Jennifer K. Simpson, President & CEO of Delcath. “The projected 657-day median OS and 1,207 day median OS in those with a partial or complete response is very impressive, and we believe speaks to the potential of the system to provide meaningful durable response.” PHP with Melphalan/HDS was developed by Delcath Systems as a targeted, whole organ therapy for the liver. It is commercially available as a device in Europe, where it is marketed as CHEMOSAT®. The system has not been approved by the U.S. Food and Drug Administration, and is undergoing Phase 3 clinical testing in the U.S. as an investigational product. About Delcath Systems Delcath Systems, Inc. is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational product—Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) —is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. We have commenced a global Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM) and a global Phase 2 clinical trial in Europe and the U.S. to investigate the Melphalan/HDS system for the treatment of primary liver cancer (HCC) and intrahepatic cholangiocarcinoma (ICC). Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S.  In Europe, our system has been commercially available since 2012 under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a wide range of cancers of the liver. Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to: our ability to repay and comply with the obligations under our senior secured convertible notes, the timing and results of the Company's  clinical trials including without limitation the OM, HCC ,and  ICC clinical trial programs,  timely enrollment and treatment of patients in the global Phase 3 FOCUS Clinical Trial for Patients with Hepatic Dominant Ocular Melanoma and the global Phase 2 HCC and ICC clinical trials, IRB or ethics committee clearance of the Phase 2 HCC/ICC  and/or Phase 3 OM  protocols from  participating sites and the timing of site activation and subject enrollment in each trial, the impact, if any, of publication of the Phase 3 trial manuscript to support the Company's efforts, the impact of the presentations at major medical conferences and future clinical results consistent with the data presented, the impact, if any  of ZE reimbursement on potential CHEMOSAT product use and sales in Germany, clinical adoption, use and resulting sales, if any, for the CHEMOSAT system to deliver and filter melphalan in Europe, the Company's ability to successfully commercialize the CHEMOSAT/Melphalan HDS system and the potential of the CHEMOSAT/Melphalan HDS system as a treatment for patients with primary and metastatic disease in the liver, our ability to obtain reimbursement for the CHEMOSAT system in various markets, the Company's ability to satisfy the remaining requirements of the FDA's Complete Response Letter and provide the same in a timely manner, approval of the current or future Melphalan HDS/CHEMOSAT system for delivery and filtration of melphalan for various indications in the U.S. and/or in foreign markets, actions by the FDA or other foreign regulatory agencies, the Company's ability to successfully enter into strategic partnership and distribution arrangements in foreign markets and the timing and revenue, if any, of the same, uncertainties relating to the timing and results of research and development projects, our ability to maintain NASDAQ listing, and uncertainties regarding the Company's ability to obtain financial and other resources for any research, development, clinical trials and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.


NEW YORK, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced today that the American Journal of Clinical Oncology has published a single-center retrospective review, in which authors found that investigational PHP with Melphalan/HDS offers promising results with a doubling of overall survival and significantly longer progression-free survival (PFS) and hepatic progression-free survival (HPFS) than other targeted therapies. Percutaneous hepatic perfusion (PHP) is a minimally invasive procedure that isolates the liver from the body’s circulatory system, so that a high dose of chemotherapy (melphalan hydrochloride) may be infused directly into the liver. Blood from the liver is then filtered to remove the chemotherapeutic agent thereby minimizing systemic exposure. The review, “Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma,” was written by a team from the Moffitt Cancer Center, including co-first authors Drs. Andrea M. Abbott and Matthew P. Doepker, and Jonathan S. Zager, the principal investigator in Delcath’s ongoing Phase 3 FOCUS study. Drs. Abbott, et al, analyzed clinical outcomes of three different non-randomized approaches used to treat 30 patients with liver metastases primarily resulting from ocular melanoma and skin melanoma. A third of the patients received PHP using melphalan delivered via the Delcath Hepatic Delivery System (Melphalan/HDS), 12 received chemoembolization (CE) and six received radioembolization with yttrium-90 (Y90). Two patients crossed over once their cancer progressed – one from PHP to Y90 and one from CE to PHP. The paper’s authors concluded that patients who received PHP with Melphalan/HDS had significantly longer median HPFS at 361 days compared to 54 days for Y90 and 80 days for CE, as well as a longer median PFS at 245 days compared to 54 days for Y90 and 52 days for CE. Median overall survival was also longest for PHP at 608 days compared to 295 days for Y90 and 265 days for CE. The authors noted that further studies, including a randomized controlled trial, would be needed to confirm whether clinically superior outcomes can be achieved with PHP compared to other liver-targeted treatments. Side effects following all treatments were similar, with most complications recorded as anorexia, abdominal pain, fatigue and nausea. Laboratory irregularities, such as thrombocytopenia and abnormal liver function tests, were seen immediately after treatment in some patients, but returned to baseline within a few days. “The vast majority of patients with metastatic ocular melanoma survive less than a year, due to the difficulty in treating metastases to the liver, which are a hallmark of this cancer. It is therefore especially gratifying to see patients with this rare disease survive almost two years after receiving PHP with Melphalan/HDS,” said Dr. Jennifer K. Simpson, President & CEO of Delcath. “We are hopeful that our ongoing Global Phase 3 FOCUS study for patient with ocular melanoma liver metastases will yield similar results, further reinforcing the benefits of our technology, and bringing us one step closer to U.S. market availability.” PHP with Melphalan/HDS was developed by Delcath Systems as a targeted, whole organ therapy for the liver. The product is commercially available in Europe under the trade name CHEMOSAT®, and is being evaluated as an experimental therapy in the U.S., where a global Phase 3 clinical trial is enrolling patients with ocular melanoma that has metastasized to the liver. About Delcath Systems Delcath Systems, Inc. is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational product—Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) —is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. We have commenced a global Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM) and a global Phase 2 clinical trial in Europe and the U.S. to investigate the Melphalan/HDS system for the treatment of primary liver cancer (HCC) and intrahepatic cholangiocarcinoma (ICC). Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S.  In Europe, our system has been commercially available since 2012 under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a wide range of cancers of the liver. Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to: our ability to repay and comply with the obligations under our senior secured convertible notes, the timing and results of the Company's  clinical trials including without limitation the OM, HCC, and  ICC clinical trial programs, timely enrollment and treatment of patients in the global Phase 3 FOCUS Clinical Trial for Patients with Hepatic Dominant Ocular Melanoma and the global Phase 2 HCC and ICC clinical trials, IRB or ethics committee clearance of the Phase 2 HCC/ICC and/or Phase 3 OM protocols from  participating sites and the timing of site activation and subject enrollment in each trial, the impact, if any, of publication of the Phase 3 trial manuscript to support the Company's efforts, the impact of the presentations at major medical conferences and future clinical results consistent with the data presented, the impact, if any of ZE reimbursement on potential CHEMOSAT product use and sales in Germany, clinical adoption, use and resulting sales, if any, for the CHEMOSAT system to deliver and filter melphalan in Europe, the Company's ability to successfully commercialize the CHEMOSAT/Melphalan HDS system and the potential of the CHEMOSAT/Melphalan HDS system as a treatment for patients with primary and metastatic disease in the liver, our ability to obtain reimbursement for the CHEMOSAT system in various markets, the Company's ability to satisfy the remaining requirements of the FDA's Complete Response Letter and provide the same in a timely manner, approval of the current or future Melphalan HDS/CHEMOSAT system for delivery and filtration of melphalan for various indications in the U.S. and/or in foreign markets, actions by the FDA or other foreign regulatory agencies, the Company's ability to successfully enter into strategic partnership and distribution arrangements in foreign markets and the timing and revenue, if any, of the same, uncertainties relating to the timing and results of research and development projects, our ability to maintain NASDAQ listing, and uncertainties regarding the Company's ability to obtain financial and other resources for any research, development, clinical trials and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.


News Article | March 3, 2017
Site: www.businesswire.com

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Total worldwide enterprise storage systems factory revenue was down 6.7% year over year while reaching $11.1 billion in the fourth quarter of 2016 (4Q16), according to the International Data Corporation (IDC) Worldwide Quarterly Enterprise Storage Systems Tracker. Total capacity shipments were up 18.3% year over year to 52.4 exabytes during the quarter. Revenue growth increased within the group of original design manufacturers (ODMs) that sell directly to hyperscale datacenters. This portion of the market was up 3.2% year over year to $1.2 billion. Sales of server-based storage declined 7.8% during the quarter and accounted for $3.4 billion in revenue. External storage systems remained the largest market segment, but the $6.4 billion in sales represented a year-over-year decline of 7.8%. It should be noted that the size of the server-based storage market has been updated this quarter to reflect a change to IDC's enterprise storage systems taxonomy. IDC's new methodology for sizing the server-based storage market is now more inclusive than in the past, thus increasing the size of the market in terms of value, systems shipped, and capacity consumed. Changes to the server-based storage market have been applied retroactively to ensure continuity with past quarters. "2016 represented a year of considerable change for the enterprise storage systems market," said Liz Conner, research manager, Storage Systems. "While the broader enterprise storage systems market has been impacted by headwinds, companies continue to increase their investments in several key areas, such as software-defined storage, cloud-based storage, all flash storage systems, and converged systems. As a result, traditional enterprise storage vendors have aligned their portfolios to meet the shifting demands." Dell Technologies was the largest external enterprise storage systems supplier during the quarter, accounting for 32.9% of worldwide revenues. HPE, IBM, and NetApp finished in a statistical tie* for the number 2 position with 10.2%, 10.1% and 10.0% of market share, respectively. HPE's share and year-over-year growth rate includes revenues from the H3C joint venture in China that began in May of 2016; as a result, the reported HPE/New H3C Group combines storage revenue for both companies globally. Hitachi rounded out the top 5 with revenue share of 7.0%. Notes: * – IDC declares a statistical tie in the worldwide enterprise storage systems market when there is less than one percent difference in the revenue share of two or more vendors. a – Dell Technologies represents the combined revenues for Dell and EMC. b – Due to the existing joint venture between HPE and the New H3C Group, IDC will be reporting external market share on a global level for HPE as "HPE/New H3C Group" starting from 2Q 2016 and going forward. In addition to the table above, an interactive graphic showing the worldwide market share of the top 5 vendors plus ODM Direct sales in the total external enterprise storage systems market over the previous five quarters is available here. Instructions on how to embed this graphic into online news articles and social media can be found by viewing this press release on IDC.com. The total All Flash Array (AFA) market generated almost $1.7 billion in revenue during the quarter, up 61.2% year over year. The Hybrid Flash Array (HFA) segment of the market continues to be a significant part of the overall market with $2.5 billion in revenue and 38.4% market share. Taxonomy Notes IDC defines an enterprise storage system (ESS) as a set of storage elements used to provide persistent data storage resources including power supplies, cooling, system enclosures, storage controllers, system cabling & external connections, and storage media (HDDs and/or flash). An enterprise storage system may be located outside of or within an application server. IDC excludes storage networking (e.g., FC switches) and non-bundled storage software when sizing the enterprise storage systems market. The information in this quantitative study is based on a branded view of the disk storage systems sale. Revenue associated with the products to the end user is attributed to the seller (brand) of the product, not the manufacturer. Original equipment manufacturer (OEM) sales are not included in this study. In this study, Hitachi Data Systems (HDS) sales do not reflect their OEM sales to Sun Microsystems and Hewlett-Packard. IDC's Worldwide Disk Storage Systems Quarterly Tracker is a quantitative tool for analyzing the global disk storage market on a quarterly basis. The Tracker includes quarterly shipments and revenues (both customer and factory), Terabytes, $/Gigabyte, Gigabyte/Unit, and Average Selling Value. Each criteria can be segmented by location, installation base, operating system, vendor, family, model, and region. For more information about IDC's Worldwide Disk Storage Systems Quarterly Tracker, please contact Lidice Fernandez at 305-351-3051 or lfernandez@idc.com. About IDC International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology, telecommunications, and consumer technology markets. With more than 1,100 analysts worldwide, IDC offers global, regional, and local expertise on technology and industry opportunities and trends in over 110 countries. IDC's analysis and insight helps IT professionals, business executives, and the investment community to make fact-based technology decisions and to achieve their key business objectives. Founded in 1964, IDC is a wholly-owned subsidiary of International Data Group (IDG), the world's leading media, data and marketing services company. To learn more about IDC, please visit www.idc.com. Follow IDC on Twitter at @IDC. All product and company names may be trademarks or registered trademarks of their respective holders.


VANCOUVER, BC--(Marketwired - February 14, 2017) - Arizona Mining Inc. (TSX: AZ) ("Arizona Mining" or the "Company") announces the results of three (3) exploration drill holes from its current program on the Taylor zinc-lead-silver sulfide deposit located on its 100%-owned Hermosa Project in Santa Cruz County, Arizona. This brings the total number of drill holes reported in the 2016-2017 program to sixty-two (62). HDS-413 is an angled drill hole (-82 degrees) drilled to infill an area southwest of the previously reported resource area. HDS-413 intersected seven (7) distinct mineralized sulfide horizons which when added together have a total cumulative mineralized thickness of 716 feet (refer to Table I). Six (6) of the mineralized zones are in the Taylor Sulfide zone and one (1) intersected the Taylor Deeps Sulfide zone. Some of the best results in the hole included: HDS-406 is an angled drill hole (-85 degrees) drilled to infill an area of the previously reported mineral resource. The drill hole encountered three (3) mineralized veins in the volcanics, four (4) mineralized horizons within the Taylor Sulfide zone and two (2) mineralized horizons in the Taylor Deeps Sulfide zone. When added together the Taylor Sulfide zone intervals have a cumulative thickness of 136.5 feet (refer to Table I). Most notable among the mineralized horizons includes: HDS-407 is a vertical infill drill hole that intersected two (2) mineralized veins; eight (8) mineralized horizons in the Taylor Sulfide zone plus a significant zone of mineralization in the Taylor Deeps Sulfide zone. Most notable among the mineralized horizons is the mineralization in the Taylor Deeps zone which assayed: For a full list of the vein, Taylor Sulfide and Taylor Deeps Sulfide mineralized intervals from these holes please refer to Table I. CEO Jim Gowans commented: "These drill results continue to confirm the continuity of the Taylor Sulfide portion of the deposit and expand the footprint of the new Taylor Deeps zone." The results of the Arizona Mining Inc. drilling have been reviewed, verified and compiled by Donald R. Taylor, MSc., PG, Chief Operating Officer for Arizona Mining Inc., a qualified person as defined by National Instrument 43-101 (NI 43-101). Mr. Taylor has more than 25 years of mineral exploration and mining experience, and is a Registered Professional Geologist through the SME (registered member #4029597). To ensure reliable sample results, the Company has a rigorous QA/QC program in place that monitors the chain-of-custody of samples and includes the insertion of blanks, duplicates, and certified reference standards at statistically derived intervals within each batch of samples. Core is photographed and split in half with one-half retained in a secured facility for verification purposes. Sample preparation (crushing and pulverizing) has been performed at ALS Minerals Laboratories, an ISO/IEC accredited lab located in Tucson, Arizona. ALS Minerals Laboratories prepares a pulp of all samples and sends the pulps to their analytical laboratory in Vancouver, B.C. Canada for analysis. ALS analyzes the pulp sample by ICP following a 4-acid digestion (ME-ICP61 for 33 elements) including Cu (copper), Pb (lead), and Zn (zinc). All samples in which Cu (copper), Pb (lead), or Zn (zinc) are greater than 10,000 ppm are rerun using four acid digestion with an ICP - AES finish (Cu-OG62; Pb-OG62; and Zn-OG62) with the elements reported in percentage (%). Silver values are determined by ICP (ME-ICP61) with all samples with silver values greater than 100 ppm repeated using four acid digestion with an ICP-AES finish (Ag-OG62) calibrated for higher levels of silver contained. Any values over 1,500 ppm Ag trigger a fire assay with gravimetric finish analysis. Gold values are determined by a 30 gm fire assay with an ICP-AES finish (Au-ICP21). Arizona Mining Inc. is a Canadian mineral exploration and development company focused on the exploration and development of its 100%-owned Hermosa Project located in Santa Cruz County, Arizona. The Taylor Deposit, a zinc-lead-silver carbonate replacement deposit, has a resource of 31.1 million tons in the Indicated Mineral Resource category grading 10.9% zinc equivalent ("ZnEq") and 82.7 million tons in the Inferred Mineral Resource category grading 11.1% ZnEq both utilizing a 4% ZnEq cutoff grade calculated in accordance with NI 43-101 guidelines (refer to the Company's news release dated October 31, 2016). The Taylor Deposit remains open to the north, west and south over land controlled by the Company and will be aggressively drilled to test the limits of the resource. The Company's other project on the Hermosa property is the Central Deposit, a silver-manganese manto oxide project. Certain information contained in this press release constitutes forward-looking statements. All statements, other than statements of historical facts, are forward looking statements including statements with respect to the Company's intentions for its Hermosa Project in Arizona, including, without limitation, performing additional drilling and metallurgical testwork on the Taylor Deposit. Forward-looking statements are often, but not always, identified by the use of words such as may, will, seek, anticipate, believe, plan, estimate, budget, schedule, forecast, project, expect, intend, or similar expressions. The forward-looking statements are based on a number of assumptions which, while considered reasonable by Arizona Mining, are subject to risks and uncertainties. In addition to the assumptions herein, these assumptions include the assumptions described in Arizona Mining's management's discussion and analysis for the year ended December 31, 2015 ("MD&A"). Arizona Mining cautions readers that forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to differ materially from those expressed in or implied by such forward-looking statements and forward-looking statements are not guarantees of future results, performance or achievement. These risks, uncertainties and factors include general business, economic, competitive, political, regulatory and social uncertainties; actual results of exploration activities and economic evaluations; fluctuations in currency exchange rates; changes in project parameters; changes in costs, including labour, infrastructure, operating and production costs; future prices of zinc, lead, silver and other minerals; variations of mineral grade or recovery rates; operating or technical difficulties in connection with exploration, development or mining activities, including the failure of plant, equipment or processes to operate as anticipated; delays in completion of exploration, development or construction activities; changes in government legislation and regulation; the ability to maintain and renew existing licenses and permits or obtain required licenses and permits in a timely manner; the ability to obtain financing on acceptable terms in a timely manner; contests over title to properties; employee relations and shortages of skilled personnel and contractors; the speculative nature of, and the risks involved in, the exploration, development and mining business; and the factors discussed in the section entitled "Risks and Uncertainties" in the MD&A. Although Arizona Mining has attempted to identify important risks, uncertainties and other factors that could cause actual performance, achievements, actions, events, results or conditions to differ materially from those expressed in or implied by the forward-looking information, there may be other risks, uncertainties and other factors that cause performance, achievements, actions, events, results or conditions to differ from those anticipated, estimated or intended. Unless otherwise indicated, forward-looking statements contained herein are as of the date hereof and Arizona Mining disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable law.


SAN FRANCISCO--(BUSINESS WIRE)--Williams-Sonoma, Inc. announced today that it will bring its family of home furnishings brands to South Korea through a franchise agreement with Hyundai Livart Furniture Co. Ltd, a leading Korean furniture manufacturer and distributor. Livart, an affiliate of Hyundai Department Store Group (HDG), will have exclusive rights to operate stores, shop-in-shops, and e-commerce for the following brands in the Williams-Sonoma, Inc. portfolio: Williams Sonoma, Pottery Barn, Pottery Barn Kids and West Elm. “We are pleased to announce our latest strategic global expansion with our new franchise partner, Livart,” said Laura Alber, President and Chief Executive Officer of Williams-Sonoma, Inc. “Livart’s market expertise and extensive retail footprint in South Korea will enable us to deliver the same high quality of service that we provide in the United States and around the world. Livart is the best partner to help bring our brands to the Korean market.” "We are honored to help bring Williams-Sonoma, Inc.’s products and services to South Korea,” said Hwa-Eung Kim, Representative Director and Chief Executive Officer of Hyundai Livart Furniture Co. Ltd. “This franchise agreement will help strengthen our competitive advantage in the domestic premium home furnishings market by complementing existing Livart brands, and we plan to leverage our diverse distribution channels to expand strategically through Seoul and other major cities.” Over the next 10 years, Livart is expected to open over 30 stores in South Korea across four Williams-Sonoma, Inc. brands. The first stores scheduled to open this spring include a combined Pottery Barn and Pottery Barn Kids store (of 924㎡/280 pyeong), a West Elm store (of 700㎡/212 pyeong) at the Hyundai City Mall Garden Five Mall, and a Williams Sonoma store (297㎡/90 pyeong) at the HDS Mokdong branch. Williams-Sonoma, Inc. is a specialty retailer of high-quality products for the home. These products, representing eight distinct merchandise strategies – Williams Sonoma, Pottery Barn, Pottery Barn Kids, West Elm, PBteen, Williams Sonoma Home, Rejuvenation, and Mark and Graham – are marketed through e-commerce websites, direct mail catalogs and retail stores. Williams-Sonoma, Inc. currently operates in the United States, Canada, Australia and the United Kingdom, offers international shipping to customers worldwide, and has unaffiliated franchisees that operate stores in the Middle East and the Philippines and stores and e-commerce websites in Mexico. Hyundai Livart, an affiliate of Hyundai Department Store Group, is a home furnishing company which provides new lifestyles to its customers in areas of home, office, built-in and diverse areas. Hyundai Livart's main brands include; Livart, Livart Neoce, Livart Ismine, Livart Kitchen, Livart Kids, H.Mondo. As described in Livart's name (Living+Art, Designing the living space through art) aims to provide its customers every day new life. This press release contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Such forward-looking statements include statements related to the success of our franchise operations in South Korea and our global expansion strategy. The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include the risk that the anticipated franchise stores or e-commerce in South Korea do not open on schedule or are not successful, that the overall franchise operations are not successful, and that we are not able to continue to execute our global expansion strategy as planned. These and other risks and uncertainties are described more fully in our Annual Report on Form 10-K for the fiscal year ended January 31, 2016 and all subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we assume no obligation to update these forward-looking statements.


Hitachi Virtual Storage Platform F800 Takes Bronze in All-Flash Storage Systems Category for Value, Performance and Innovation SANTA CLARA, CA--(Marketwired - February 22, 2017) - Hitachi Data Systems, a wholly owned subsidiary of Hitachi Ltd. ( : 6501), has been recognized by TechTarget's Storage Media Group as a winner of the 2016 Products of the Year Awards in the all-flash storage systems category for its Hitachi Virtual Storage Platform (VSP) F800 array. The VSP F800 stood against six other finalists, including products from flash-only vendors as well as vendors that offer all-flash versions of hybrid arrays. The criteria for winners in the all-flash storage system category included levels of innovation and performance, as well as ease of integration into existing environments. Additionally, functionality, value, and ease of manageability were compared to identify the top three all-flash systems of 2016. While many all-flash arrays on the market are built to support a single application, VSP F800 is designed to support multiple applications and deliver superior uptime and performance. VSP F800 is built on Hitachi's flash-aware storage operating system, the Storage Virtualization Operating System (SVOS), which provides capacity reduction efficiencies, quality of service (QoS) controls, best-in-class cloud tiering and integration with a broad range of data center applications. This enables VSP F800 to consolidate many application workloads on a single system for maximum IT efficiency and cost savings. All VSP F series are built on Hitachi's intelligent flash modules (FMDs) instead of SSDs. The FMDs perform more consistently than SSDs and reduce controller overhead by shouldering flash related tasks. By delivering up to 1.4 million IOPS, VSP F series lets customers run applications that require the highest transaction rates. As a result, application response times are much faster than traditional SSD-based AFAs that are limited to performing data reduction on the array controller. The data reduction features in SVOS scales VSP F800 to a significant 1.4PB of effective capacity. Other systems in the VSP F Series include the VSP F400, F600 and F1500 all-flash arrays. Hitachi Data Systems offers deep expertise in delivering world-class product support, nondisruptive data migration services, and fault-tolerant solutions. The future demands flash technology to meet increasing workloads, and the VSP portfolio and related offerings are here to meet those needs. "Hitachi VSP F800 is based on the strength of HDS' proven hardened array," noted a Storage Magazine judge. "The manufacturer's $69,860 list [price] makes VSP F800 a good value at the price." About Hitachi Data Systems Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help global organizations open new revenue streams, increase efficiencies, improve customer experience and ensure rapid time to market in the digital age. Only Hitachi Data Systems powers the digital enterprise by integrating the best information technology and operational technology from across the Hitachi family of companies. We combine this experience with Hitachi expertise in the internet of things to deliver the exceptional insights business and society need to transform and thrive. Visit us at HDS.com. About Hitachi, Ltd. Hitachi, Ltd. ( : 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges. The company's consolidated revenues for fiscal 2015 (ended March 31, 2016) totaled 10,034.3 billion yen ($88.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 335,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including power & infrastructure systems, information & telecommunication systems, construction machinery, high functional materials & components, automotive systems, healthcare and others. For more information on Hitachi, please visit the company's website at http://www.hitachi.com. HITACHI is a trademark or registered trademark of Hitachi, Ltd. All other trademarks, service marks, and company names are properties of their respective owners.


ATLANTA, Feb. 16, 2017 (GLOBE NEWSWIRE) -- HD Supply Holdings, Inc. (Nasdaq:HDS), one of the largest industrial distributors in North America, today announced that the company is planning to release its fourth-quarter and full-year 2016 results via press release on Tuesday, March 14th, at 6 a.m. (ET) to be followed by a conference call at 8 a.m. (ET). The conference call and presentation materials can be accessed via webcast by logging on from the Investor Relations section of the company's website at hdsupply.com. The online replay will remain available for a limited time following the call. To learn more about HD Supply, please visit the company's website at hdsupply.com. HD Supply uses its website as a channel of distribution for material company information. Financial and other material information regarding HD Supply is routinely posted on the company's website and is readily accessible. About HD Supply: HD Supply (NASDAQ:HDS) (www.hdsupply.com) is one of the largest industrial distributors in North America. The company provides a broad range of products and value-add services to approximately 500,000 customers with leadership positions in maintenance, repair and operations, infrastructure and specialty construction sectors. Through approximately 550 locations across 48 states and six Canadian provinces, the company's approximately 13,000 associates provide localized, customer-driven services including jobsite delivery, will-call or direct-ship options, diversified logistics and innovative solutions that contribute to its customers' success.

Loading HDS collaborators
Loading HDS collaborators